PALUDRINE

This brand name is authorized in Nigeria, Netherlands, United Kingdom

Active ingredients

The drug PALUDRINE contains one active pharmaceutical ingredient (API):

1 Proguanil UNII R71Y86M0WT - PROGUANIL HYDROCHLORIDE

Proguanil is an antimalarial drug and dihydrofolate reductase inhibitor. It acts like the other antifolate antimalarials by interfering with the folic-folinic acid systems and thus exerts its effect mainly at the time the nucleus is dividing. Proguanil is effective against the exoerythrocytic forms of some strains of plasmodium falciparum but it has little or no activity against the exoerythrocytic forms of p. Vivax. Read about Proguanil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PALUDRINE Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P01BB01	Proguanil	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BB Biguanides
Discover more medicines within P01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147068, 36397
Country: NG	Registered Drug Product Database	Identifier(s): 04-0364
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 2070